'Eligibility challenges' derail specialized trial of GSK's Zejula in breast cancer

0

26.04.2023 20:19

Fiercepharma.com

'Eligibility challenges' derail specialized trial of GSK's Zejula in breast cancer fkansteiner Wed, 04/26/2023 - 13:19

СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *